Results of Operations and Financial Condition. On August 4, 2026, The Chemours Company (the “Company”) issued a press release regarding its second quarter 2026 financial results. A copy of the press release is furnished hereto as Exhibit 99.1. The Company will post to its investor relations website, investors.chemours.com, an investor presentation by 8:00 a.m. Eastern Daylight Time on Wednesday, August 5, 2026, for its conference call scheduled for that time. The information furnished with th…

Regulation FD Disclosure. On June 24, 2026, Chemours issued a press release announcing the matters described in this Current Report on Form 8-K. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. Forward-Looking Statements This Current Report on Form 8-K contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertai…

Entry into a Material Definitive Agreement. On June 23, 2026, The Chemours Company (“Chemours”) agreed to a proposed Consent Decree with the United States Environmental Protection Agency (the “EPA”) and the West Virginia Department of Environmental Protection (the “WVDEP”) to resolve claims asserted by the EPA and the WVDEP with respect to PFAS emissions and other alleged activities at certain Chemours facilities, including the Washington Works, Fayetteville Works and Chambers Works facilitie…

Results of Operations and Financial Condition. On May 5, 2026, The Chemours Company (the “Company”) issued a press release regarding its first quarter 2026 financial results. A copy of the press release is furnished hereto as Exhibit 99.1. The Company will post to its investor relations website, investors.chemours.com, an investor presentation by 8:00 a.m. Eastern Daylight Time on Wednesday, May 6, 2026, for its conference call scheduled for that time. The information furnished with this repo…

The filing is about the approval of a new equity and incentive plan, not a management change.

Creation of a Direct Financial Obligation or an Obligation under Off-Balance Sheet Arrangement of a Registrant. The information set forth in

Entry into a Material Definitive Agreement. The information set forth in

Other Events. On March 12, 2026, The Chemours Company (the “Company”) closed the private offering (the “Offering”) of $700,000,000 aggregate principal amount of the Company’s 7.875% Senior Notes due 2034 (the “Notes”), pursuant to the Purchase Agreement (the “Purchase Agreement”), dated as of February 26, 2026, by and among the Company, the guarantor named therein and Goldman Sachs & Co. LLC, as representative of the several initial purchasers named therein. The Notes were issued pursuant to…

Results of Operations and Financial Condition. On February 19, 2026, The Chemours Company (the “Company”) issued a press release regarding its fourth quarter and full year 2025 financial results. A copy of the press release is furnished hereto as Exhibit 99.1. The Company will post to its investor relations website, investors.chemours.com, an investor presentation by 8:00 a.m. Eastern Daylight Time on Friday, February 20, 2026, for its conference call scheduled for that time. The information…

Entry into a Material Definitive Agreement On January 15, 2026 (the “Effective Date”), The Chemours Company (the “Company”), through its subsidiary, The Chemours (Taiwan) Company Limited (“Seller”), entered into four separate Real Estate Sale and Purchase Agreements (collectively, the “Purchase Agreements”) with four affiliated entities: Century Wind Power Co., Ltd., Century Iron and Steel Industrial Co., Ltd., Century Huaxin Wind Energy Co., Ltd. and Mr. Lai Wen-Hsiang (collectively, the “Bu…

Results of Operations and Financial Condition. On November 6, 2025, The Chemours Company (the “Company”) issued a press release regarding its third quarter 2025 financial results. A copy of the press release is furnished hereto as Exhibit 99.1. Senior management's prepared remarks are attached as Exhibit 99.2 to this report. The Company will post to its investor relations website, investors.chemours.com, an investor presentation and prepared remarks by 8:00 a.m. Eastern Daylight Time on Frida…

The filing discloses the adoption of a new Executive Severance Policy, which is a compensatory arrangement rather than a specific management departure or appointment.

Entry into a Material Definitive Agreement. On October 15, 2025 (the “Amendment No. 4 Effective Date”), The Chemours Company (the “Company”) entered into Amendment No. 4 (the “Amendment”) by and among the Company, The Chemours Company FC, LLC, the lenders from time to time party thereto and JPMorgan Chase Bank, N.A., as administrative agent (the “Administrative Agent”), which amends the Second Amended and Restated Credit Agreement, dated as of August 18, 2023, among the Company, the lenders f…

Creation of a Direct Financial Obligation or an Obligation under Off-Balance Sheet Arrangement of a Registrant. The information set forth in

Chair of the Board — Dawn Farrell: The Chair of the Board is resigning to take a government position, which is a genuine departure of a senior governance figure, though the move is driven by an external opportunity rather than internal distress.

Results of Operations and Financial Condition. On August 5, 2025, The Chemours Company (the “Company”) issued a press release regarding its second quarter 2025 financial results. A copy of the press release is furnished hereto as Exhibit 99.1. Senior management's prepared remarks are attached as Exhibit 99.2 to this report. The Company will post to its investor relations website, investors.chemours.com, an investor presentation and prepared remarks by 8:00 a.m. Eastern Daylight Time on Wednes…

Entry into a Material Definitive Agreement. On August 3, 2025, The Chemours Company (“Chemours”), Corteva, Inc. and its subsidiary EIDP Inc. (formerly known as E. I. du Pont de Nemours and Company and together with its parent, Corteva Inc., referred to as “Corteva”) and DuPont de Nemours, Inc. (“DuPont” and together with Chemours and Corteva, the “Companies”) agreed to a proposed Judicial Consent Order with the State of New Jersey to comprehensively resolve all pending environmental and other…

Other Events . On August 4, 2025, Chemours, DuPont and Corteva issued a joint press release announcing the matters described in this Current Report on Form 8-K . A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. Forward-Looking Statements This Current Report on Form 8-K contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act, and Section 21E of the Securities Exch…

Results of Operations and Financial Condition. On May 6, 2025, The Chemours Company (the “Company”) issued a press release regarding its first quarter 2025 financial results. A copy of the press release is furnished hereto as Exhibit 99.1. The Company will post to its investor relations website, investors.chemours.com, an investor presentation and prepared remarks by 8:00 a.m. Eastern Daylight Time on Wednesday, May 7, 2025, for its conference call scheduled for that time. The information fur…

Director — Guillaume Pepy: A sitting director chose not to seek re-election, resulting in the loss of a board member, but the filing explicitly states there was no disagreement with the company.

Results of Operations and Financial Condition. On February 18, 2025, The Chemours Company (the “Company”) issued a press release regarding its fourth quarter and full year 2024 financial results. A copy of the press release is furnished hereto as Exhibit 99.1. The Company will post to its investor relations website, investors.chemours.com, an investor presentation and prepared remarks by 8:00 a.m. Eastern Daylight Time on Tuesday, February 18, 2025, for its conference call scheduled for that…

Director — Curtis V. Anastasio: The filing discloses a director's decision not to seek re-election at the upcoming annual meeting, which is a routine board turnover event rather than a sudden executive departure.

Director — Leslie M. Turner: The filing discloses the appointment of a new independent director to the Board, which is a routine governance event and not a departure of a senior executive.

Director — Joseph D. Kava: The filing discloses the appointment of a new independent director to the Board, which is a routine governance event and not a departure of a senior executive.

Entry into a Material Definitive Agreement. On December 13, 2024, The Chemours Company (the “Company”) entered into Amendment No. 2 (the “Second Amendment”) among the Company, certain subsidiaries of the Company, the lenders from time to time party thereto and JPMorgan Chase Bank, N.A., as administrative agent (the “Administrative Agent”), which amends the Second Amended and Restated Credit Agreement, dated as of August 18, 2023, among the Company, the lenders from time to time party thereto…